These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31346815)

  • 1. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis (Review).
    Carabotti M; Annibale B
    Tech Coloproctol; 2019 Jun; 23(6):597-599. PubMed ID: 31346815
    [No Abstract]   [Full Text] [Related]  

  • 2. Is mesalazine treatment effective in the prevention of diverticulitis? A review.
    Stefanelli G; Viscido A; Valvano M; Vernia F; Frieri G; Ashktorab H; Latella G
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8164-8176. PubMed ID: 32767345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine in preventing acute diverticulitis occurrence: a meta-analysis of randomized controlled trials.
    Tursi A; Picchio M
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):409-11. PubMed ID: 27689212
    [No Abstract]   [Full Text] [Related]  

  • 4. New medical strategies for the management of acute diverticulitis.
    Tursi A
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1293-304. PubMed ID: 26289102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials.
    Raskin JB; Kamm MA; Jamal MM; Márquez J; Melzer E; Schoen RE; Szalóki T; Barrett K; Streck P
    Gastroenterology; 2014 Oct; 147(4):793-802. PubMed ID: 25038431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.
    Stollman N; Magowan S; Shanahan F; Quigley EM;
    J Clin Gastroenterol; 2013 Aug; 47(7):621-9. PubMed ID: 23426454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.
    Tursi A; Joseph RE; Streck P
    Dig Dis Sci; 2011 Nov; 56(11):3112-21. PubMed ID: 21567193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis.
    Urushidani S; Kuriyama A; Matsumura M
    J Gastroenterol Hepatol; 2018 Jan; 33(1):12-19. PubMed ID: 28623877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
    Festi D; Colecchia A
    Am J Gastroenterol; 2009 Feb; 104(2):532. PubMed ID: 19174809
    [No Abstract]   [Full Text] [Related]  

  • 10. Diverticular disease: what is the best long-term treatment?
    Tursi A
    Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):77-8. PubMed ID: 20134488
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
    Kruis W; Kardalinos V; Eisenbach T; Lukas M; Vich T; Bunganic I; Pokrotnieks J; Derova J; Kondrackiene J; Safadi R; Tuculanu D; Tulassay Z; Banai J; Curtin A; Dorofeyev AE; Zakko SF; Ferreira N; Björck S; Diez Alonso MM; Mäkelä J; Talley NJ; Dilger K; Greinwald R; Mohrbacher R; Spiller R
    Aliment Pharmacol Ther; 2017 Aug; 46(3):282-291. PubMed ID: 28543263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalamine Does Not Help Prevent Recurrent Acute Colonic Diverticulitis: Meta-Analysis of Randomized, Placebo-Controlled Trials.
    Khan MA; Ali B; Lee WM; Howden CW
    Am J Gastroenterol; 2016 Apr; 111(4):579-81. PubMed ID: 27125717
    [No Abstract]   [Full Text] [Related]  

  • 13. Systematic review of medical therapy to prevent recurrent diverticulitis.
    Unlü C; Daniels L; Vrouenraets BC; Boermeester MA
    Int J Colorectal Dis; 2012 Sep; 27(9):1131-6. PubMed ID: 22576905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
    Cohen HD; Das KM
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
    Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diverticulosis/diverticulitis? What are conservative therapy possibilities?].
    Rinas U; Adamek HE
    Med Klin (Munich); 2006 Jan; 101(1):49-57; quiz 58-9. PubMed ID: 16418814
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
    Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
    Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration.
    Parente F; Bargiggia S; Prada A; Bortoli A; Giacosa A; Germanà B; Ferrari A; Casella G; De Pretis G; Miori G;
    Int J Colorectal Dis; 2013 Oct; 28(10):1423-31. PubMed ID: 23754545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing diverticulitis: mesalamine may still be indicated in the decision.
    Floch MH
    Gastroenterology; 2015 Apr; 148(4):856. PubMed ID: 25726738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.